TICKERNOMICS Sign up
Last Update: 2024-03-28 02:14:00
Apyx Medical Corp ( APYX ) https://www.apyxmedical.com
1.28USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
-53.79%
APYX
SPY
32.74%
-86.98%
APYX
SPY
92.93%
-79.71%
APYX
SPY
224.41%
-66.58%
APYX
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
45.73
35.26
0.23
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-3.00
0.84
1.70
0.04
0.00
-2.29
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-29.03
49.94
-26.70
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
10.0515
-31.83
-34.86
1.55
Other Earnings and Cash Flow Stats:
Apyx Medical Corp ( APYX ) Net Income TTM ($MM) is -20.02
Apyx Medical Corp ( APYX ) Operating Income TTM ($MM) is -21.96
Apyx Medical Corp ( APYX ) Owners' Earnings Annual ($MM) is -8.42
Apyx Medical Corp ( APYX ) Current Price to Owners' Earnings ratio is -5.27
Apyx Medical Corp ( APYX ) EBITDA TTM ($MM) is -21.12
Apyx Medical Corp ( APYX ) EBITDA Margin is -26.70%
Capital Allocation:
Apyx Medical Corp ( APYX ) has paid 0.00 dividends per share and bought back -0.127888 million shares in the past 12 months
Apyx Medical Corp ( APYX ) has increased its debt by 32.499 million USD in the last 12 months
Capital Structure:
Apyx Medical Corp ( APYX ) Interest-bearing Debt ($MM) as of last quarter is 33
Apyx Medical Corp ( APYX ) Annual Working Capital Investments ($MM) are -4
Apyx Medical Corp ( APYX ) Book Value ($MM) as of last quarter is 26
Apyx Medical Corp ( APYX ) Debt/Capital as of last quarter is 124%
Other Balance Sheet Stats:
Apyx Medical Corp ( APYX ) has 43 million in cash on hand as of last quarter
Apyx Medical Corp ( APYX ) has 12 million of liabilities due within 12 months, and long term debt 42 as of last quarter
Apyx Medical Corp ( APYX ) has 34 common shares outstanding as of last quarter
Apyx Medical Corp ( APYX ) has 0 million USD of preferred stock value
Academic Scores:
Apyx Medical Corp ( APYX ) Altman Z-Score is 0.49 as of last quarter
Apyx Medical Corp ( APYX ) Piotroski Score is 5.00 as of last quarter
Corporate Governance:
Apyx Medical Corp ( APYX ) largest shareholder is owning shares at 0.00 ($MM) value
Matthew C Hill(an insider) Bought 2500 shares of Apyx Medical Corp ( APYX ) for the amount of $5475.00 on 2023-12-12
12.72% of Apyx Medical Corp ( APYX ) is held by insiders, and 72.27% is held by institutions
Apyx Medical Corp ( APYX ) went public on 1987-01-01
Other Apyx Medical Corp ( APYX ) financial metrics:
FCF:-8.69
Unlevered Free Cash Flow:-4.79
EPS:-0.53
Operating Margin:-29.03
Gross Profit Margin:49.94
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-69.35
Beta:1.55
Buffet's Owners Earnings:-8.42
Price to Owner's Earnings:-5.27
About Apyx Medical Corp ( APYX ) :
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and laparoscopic surgical procedures. The company's Helium Plasma Technology products are marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It also offers hand pieces for open and laparoscopic procedures, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.